Steven A Markel sold $4.9M of MKL
director at MARKEL CORP. 3,000 shares at an average of $1,638.39, traded May 21, 2024, filed May 23, 2024.
Score components
- +15RoleDirector
- +25Trade size$4.9M at market
- 0Share of holdings soldSold 4.3% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -2.7%, 3m -3.2%, 6m +6.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001096343-24-000067, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -187 | $1,634.75 | $306k | 69,481 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -55 | $1,635.03 | $90k | 69,426 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -598 | $1,635.49 | $978k | 68,828 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -377 | $1,636.40 | $617k | 68,451 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -379 | $1,637.38 | $621k | 68,072 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -340 | $1,638.53 | $557k | 67,732 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -375 | $1,639.60 | $615k | 67,357 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -193 | $1,640.64 | $317k | 67,164 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -120 | $1,641.46 | $197k | 67,044 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -138 | $1,642.74 | $227k | 66,906 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -31 | $1,643.55 | $51k | 66,875 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -57 | $1,644.57 | $94k | 66,818 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -76 | $1,646.31 | $125k | 66,742 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -14 | $1,647.35 | $23k | 66,728 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -40 | $1,647.97 | $66k | 66,688 | May 23, 2024 |
| May 21, 2024 | SOpen-market sale Common Stock10b5-1 | -20 | $1,649.36 | $33k | 66,668 | May 23, 2024 |
Related signals
Other insiders at MARKEL CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | MKLsell MARKEL CORP | Greta J Harris director | $140k 76 shares | -11% | |
| 53Moderate | MARKEL CORP | Diane Leopold director | $269k 150 shares | +7% | |
| 47Moderate | MARKEL CORP | A. Lynne Puckett director | $102k 57 shares | +4% | |
| 37Weak | MKLsell MARKEL CORP | Simon Wilson EVP and CEO, Markel Insurance | $208k 100 shares | -4% | |
| 20Weak | MARKEL CORP | Steven A Markel director | $2.8M 1,330 shares | -2% | |
| 18Weak | MARKEL CORP | Steven A Markel director | $357k 170 shares | -0% | |
| 44Moderate | MARKEL CORP | Simon Wilson CEO, Markel Insurance | $155k 75 shares | -4% | |
| 31Weak | MKLsell MARKEL CORP | Meade P. Grandis CAO and Controller | $149k 75 shares | -21% | |
| 39Weak | MARKEL CORP | Greta J Harris director | $168k 90 shares | -12% | |
| 21Weak | MKLbuy MARKEL CORP | Lawrence A Cunningham director | $46k 25 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.